HilleVax Statistics

Total Valuation

HilleVax has a market cap or net worth of $89.72 million. The enterprise value is -$74.62 million.

Market Cap	89.72M
Enterprise Value	-74.62M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

HilleVax has 48.23 million shares outstanding. The number of shares has increased by 27.71% in one year.

Current Share Class	48.23M
Shares Outstanding	48.23M
Shares Change (YoY)	+27.71%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	5.27%
Owned by Institutions (%)	55.46%
Float	28.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.49
P/TBV Ratio	0.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.25, with a Debt / Equity ratio of 0.14.

Current Ratio	14.25
Quick Ratio	13.68
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.60

Financial Efficiency

Return on equity (ROE) is -62.24% and return on invested capital (ROIC) is -30.39%.

Return on Equity (ROE)	-62.24%
Return on Assets (ROA)	-28.90%
Return on Capital (ROIC)	-30.39%
Revenue Per Employee	n/a
Profits Per Employee	-$1.67M
Employee Count	90
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.61% in the last 52 weeks. The beta is 0.81, so HilleVax's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-87.61%
50-Day Moving Average	1.89
200-Day Moving Average	6.97
Relative Strength Index (RSI)	44.79
Average Volume (20 Days)	317,324

Short Selling Information

The latest short interest is 1.21 million, so 2.52% of the outstanding shares have been sold short.

Short Interest	1.21M
Short Previous Month	1.21M
Short % of Shares Out	2.52%
Short % of Float	4.28%
Short Ratio (days to cover)	8.84

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-135.87M
Pretax Income	-156.27M
Net Income	-150.28M
EBITDA	-134.04M
EBIT	-135.87M
Earnings Per Share (EPS)	-$3.09

Full Income Statement

Balance Sheet

The company has $189.31 million in cash and $24.97 million in debt, giving a net cash position of $164.34 million or $3.41 per share.

Cash & Cash Equivalents	189.31M
Total Debt	24.97M
Net Cash	164.34M
Net Cash Per Share	$3.41
Equity (Book Value)	184.27M
Book Value Per Share	3.82
Working Capital	183.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$112.21 million and capital expenditures -$1.15 million, giving a free cash flow of -$113.36 million.

Operating Cash Flow	-112.21M
Capital Expenditures	-1.15M
Free Cash Flow	-113.36M
FCF Per Share	-$2.35

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HilleVax does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.71%
Shareholder Yield	-27.71%
Earnings Yield	-167.51%
FCF Yield	-126.35%

Analyst Forecast

The average price target for HilleVax is $2.33, which is 25.27% higher than the current price. The consensus rating is "Hold".

Price Target	$2.33
Price Target Difference	25.27%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-34.00%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1